In recent weeks, Asian markets have shown resilience with Chinese equities advancing and Japanese indices reaching record highs, driven by robust domestic demand and optimism in the technology sector. This environment of cautious optimism presents opportunities for investors to explore small-cap stocks that may be trading below their intrinsic value, especially those showing signs of insider action which can indicate confidence in the company's future prospects.

Top 10 Undervalued Small Caps With Insider Buying In Asia

Name PE PS Discount to Fair Value Value Rating Security Bank 4.2x 0.9x 32.91% ★★★★★★ Dicker Data 19.4x 0.6x -11.53% ★★★★☆☆ Shoucheng Holdings 43.9x 9.5x 46.46% ★★★☆☆☆ Integral Diagnostics 58.2x 1.1x 45.35% ★★★☆☆☆ Centurion 12.2x 4.2x -5.84% ★★★☆☆☆ East West Banking 3.2x 0.8x 14.11% ★★★☆☆☆ PSC 11.6x 0.5x 47.98% ★★★☆☆☆ SiteMinder NA 3.3x 40.38% ★★★☆☆☆ CapitaLand China Trust NA 3.9x -1.21% ★★★☆☆☆ Nufarm NA 0.3x -131.82% ★★★☆☆☆

Click here to see the full list of 59 stocks from our Undervalued Asian Small Caps With Insider Buying screener.

Let's review some notable picks from our screened stocks.

Centuria Industrial REIT

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Centuria Industrial REIT is a real estate investment trust that focuses on investing in industrial properties, with a market capitalization of approximately A$2.5 billion.

Operations: Centuria Industrial REIT generates revenue primarily from its investments in industrial properties, with recent figures showing a revenue of A$245.69 million. The company has shown a notable trend in its gross profit margin, reaching 90.54% as of the latest data point. Operating expenses have been consistent, impacting net income margins which have fluctuated significantly over the periods observed.

PE: 13.3x

Centuria Industrial REIT, a player in the industrial property sector, is drawing attention due to its potential value. Despite relying solely on external borrowing for funding, which carries higher risk compared to customer deposits, earnings are forecasted to grow 7.68% annually. Insider confidence is evident with Roger Dobson's recent purchase of 65,000 shares worth A$206K in March 2026. The company also affirmed a quarterly cash dividend of A$0.042 per unit for March-end distribution.

Click here and access our complete valuation analysis report to understand the dynamics of Centuria Industrial REIT. Understand Centuria Industrial REIT's track record by examining our Past report.ASX:CIP Ownership Breakdown as at May 2026

Integral Diagnostics

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Integral Diagnostics operates diagnostic imaging facilities, with a market capitalization of A$767.82 million.

Story Continues

Operations: The primary revenue stream is from the operation of diagnostic imaging facilities, generating A$767.82 million. The gross profit margin has shown a trend around 31-32% in recent periods. Operating expenses are significant, with general and administrative expenses contributing a notable portion. Non-operating expenses have also impacted net income margins, which have fluctuated over time but recently showed improvement to 1.83%.

PE: 58.2x

Integral Diagnostics, a player in the Asian healthcare sector, is drawing attention with its recent financial performance and growth strategy. For the half-year ending December 2025, sales surged to A$393.48 million from A$252.87 million year-over-year, marking a substantial revenue increase to A$394.09 million from A$253.42 million previously. Despite having higher-risk funding sources due to reliance on external borrowing, IDX's earnings forecast predicts annual growth of 32.76%. The company is actively pursuing M&A opportunities and expanding with new sites in Australia while integrating past mergers for synergy benefits. Leadership will transition smoothly as Jason Martinez takes over as CEO by August 2026 following Dr Ian Kadish's tenure ensuring continuity in strategic initiatives focused on sustainable business practices and expansion within a consolidating market landscape.

Delve into the full analysis valuation report here for a deeper understanding of Integral Diagnostics. Assess Integral Diagnostics' past performance with our detailed historical performance reports.ASX:IDX Share price vs Value as at May 2026

Supply Network

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Supply Network is engaged in the provision of aftermarket parts for the commercial vehicle market, with a market cap of A$1.11 billion.

Operations: The company generates revenue primarily from the provision of aftermarket parts for the commercial vehicle market, with recent revenue reported at A$378.42 million. The cost of goods sold (COGS) is A$213.47 million, leading to a gross profit margin of 43.59%. Operating expenses amount to A$101.66 million, impacting net income which stands at A$43.10 million with a net income margin of 11.39%.

PE: 32.0x

Supply Network, a smaller player in Asia's market, has shown promising financial growth with sales reaching A$200.14 million for the half-year ending December 2025, up from A$171.17 million the previous year. Their net income improved to A$22.86 million from A$19.79 million, indicating solid performance despite relying on external borrowing for funding. Insider confidence is evident with recent share purchases in early 2026, suggesting belief in future earnings growth projected at 15% annually.

Take a closer look at Supply Network's potential here in our valuation report. Gain insights into Supply Network's past trends and performance with our Past report.ASX:SNL Share price vs Value as at May 2026

Key Takeaways

Discover the full array of 59 Undervalued Asian Small Caps With Insider Buying right here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Contemplating Other Strategies?

Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:CIP ASX:IDX and ASX:SNL.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments